Evaluation of the Antitumor Activity of Dacomitinib in Models of Human Bladder Cancer

類似資料

• Efficacy of dacomitinib in patients with EGFR‐mutated NSCLC and brain metastases
  著者:: Jinyao Zhang, 等
  出版事項: (2021-12-01)
• Virtual screening of Osimertinib and Dacomitinib Analogues with potential activity on EGFR (T790M and l858R Mutations) for non-small cell lung cancer treatment
  著者:: Leydis Luna Torres, 等
  出版事項: (2021-10-01)
• The difference between dacomitinib and afatinib in effectiveness and safety in first-line treatment of patients with advanced EGFR-mutant non-small cell lung cancer: a real-world observational study
  著者:: Wen-Chien Cheng, 等
  出版事項: (2024-02-01)
• Effects of H2-Receptor Antagonists on the Exposure of Dacomitinib
  著者:: Jian Liu, 等
  出版事項: (2024-01-01)
• Real-world data of dacomitinib as first-line treatment for patients with EGFR-mutant non-small-cell lung cancer
  著者:: Ji Eun Shin, 等
  出版事項: (2025-02-01)